AAV-based drugs
AAV-based drugs
Revolutionizing AAV Quality for Safer Gene Therapies
🔬 Discover how advancements in AAV quality control can enhance cell and gene therapy! 🧬 Standardized protocols lead to safer treatments! 📈✨
Unlocking AV and AAV Manufacturing Secrets with Analytics
1. 🔍 Robust processing and advanced analytics are vital for consistent quality in viral vector manufacturing. 🧬 iCELLis simplifies downstream processing. 2. Analytics Key to AV and AAV Manufacturing 🔍 Robust processing and advanced analytics are vital for consistent product quality in viral vector manufacturing. 🧬 Scaling up requires comparability studies and iCELLis simplifies downstream processing. Analytical methods like ELISA, PCR, and light scattering are essential for process optimization. Challenges include removing empty capsids and adapting process analytic technology.
Roche Abandons AC Immune Collaboration Returns Drugs
📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅
Breakthrough: New Cell Type for Better AAV-Based Drugs!
🔬 Researchers are searching for the perfect cell type to produce rAAVs for gene therapies. 🧪 HEK293 and CHO cells are being considered. 🐹💡🌐
